Dawn Rusk

Mar 20, 2024 | onlinelibrary.wiley.com | Linda Marshall |Rajiv Pruthi |Ahmad Al-Huniti |Dawn Rusk

Ε-Aminocaproic acid oral solution (EACA OS) is the only commercially available antifibrinolytic for patients who cannot swallow tablets. Insurance denials and high costs remain barriers to its use. To determine the safety and efficacy of crushed tranexamic acid tablets in water (cTXAw) for children with bleeding disorders. We retrospectively reviewed records of children ( .1). No patients had adverse effects.